5-amino-1mq and cd38 inhibitor synergy nad+ Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Frontiers | Nicotinamide N-methyltransferase (NNMT):
Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Discovery of a First in Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy Journal of Medicinal Chemistry NAD+ metabolism and its roles in cellular processes during ageing PMC Dysregulation of Niacin Derived NAD+ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17



